1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Regenerative Medicine Minnesota Research Grants is sponsored by Regenerative Medicine Minnesota. These research grants support Minnesota scientific and medical research with the potential to translate to clinical advances in regenerative medicine.
The program aims to address challenges in areas like stem cell survival, creating human skeletal muscle with aligned fibers, and predicting disease risk and therapeutic outcomes using iPSC organoids.
Get alerted about grants like this
Get emailed when new opportunities from “Regenerative Medicine Minnesota” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers conducting scientific and medical research in Minnesota with potential for clinical advances in regenerative medicine. Confirm the full requirements in the official notice before applying.
Regenerative Medicine Minnesota Research Grants is funded by Regenerative Medicine Minnesota. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Minnesota. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleUSDA's FY2026 GusNIP Produce Prescription Program will make roughly 12 awards of up to $500,000 over three years — with no matching requirement — to nonprofits and government agencies that partner with healthcare providers to prescribe fresh fruits and vegetables. Here is who is eligible, why the mandatory clinical partner is the whole game, how the evidence base got strong enough to matter, and how to build a July 16 application.
Read articleEPA's Gulf of America Farmer-to-Farmer program awards $1.5M-$2.5M grants for farmer-led organizations scaling regenerative agriculture. Applications due June 19, 2026.
Read article